{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:55:14Z","timestamp":1773017714186,"version":"3.50.1"},"reference-count":45,"publisher":"Wiley","issue":"6b","license":[{"start":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T00:00:00Z","timestamp":1254528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the hypermethylation status of the promoter regions of tumour suppressor genes in breast tissues from healthy women and identify the determinants of these epigenetic changes. Questionnaires and breast tissues were collected from healthy women without a history of cancer and undergoing reduction mammoplasty (<jats:italic>N<\/jats:italic>= 141). Methylation for <jats:italic>p16<jats:sup>INK4<\/jats:sup>, BRCA1, ER\u03b1<\/jats:italic> and <jats:italic>RAR\u2010\u03b2<\/jats:italic> promoter regions from breast tissues were determined by methylation specific PCR. Associations were examined with chi\u2010square and Fisher\u2019s exact test as well as logistic regression. All statistical tests were two\u2010sided. <jats:italic>p16<jats:sup>INK4<\/jats:sup>, BRCA1, ER\u03b1<\/jats:italic> and <jats:italic>RAR\u2010\u03b2<\/jats:italic> hypermethylation were identified in 31%, 17%, 9% and 0% of the women, respectively. Women with <jats:italic>BRCA1<\/jats:italic> hypermethylation had an eight\u2010fold increase in the risk of <jats:italic>ER\u03b1<\/jats:italic> hypermethylation (<jats:italic>P<\/jats:italic>= 0.007). <jats:italic>p16<jats:sup>INK4<\/jats:sup><\/jats:italic> hypermethylation was present in 28% of African\u2010Americans, but 65% in European\u2010Americans (<jats:italic>P<\/jats:italic>= 0.02). There was an increased likelihood of <jats:italic>p16<jats:sup>INK4<\/jats:sup><\/jats:italic> or <jats:italic>BRCA1<\/jats:italic> hypermethylation for women with family history of cancer (OR 2.3; 95%CI: 1.05\u20134.85 and OR 5.0; 95%CI: 1.55\u201315.81, respectively). <jats:italic>ER\u03b1<\/jats:italic> hypermethylation was associated with family history of breast cancer (OR 6.6; 95%CI: 1.58\u201327.71). After stratification by race, <jats:italic>p16<jats:sup>INK4<\/jats:sup><\/jats:italic> in European\u2010Americans and <jats:italic>BRCA1<\/jats:italic> hypermethylation in African\u2010Americans were associated with family history of cancer (OR 3.8; 95%CI: 1.21\u201312.03 and OR 6.5; 95%CI: 1.33\u201331.32, respectively). Gene promoter hypermethylation was commonly found in healthy breast tissues from women without cancer, indicating that these events are frequent and early lesions. Race and family history of cancer increase the likelihood of these early events.<\/jats:p>","DOI":"10.1111\/j.1582-4934.2009.00924.x","type":"journal-article","created":{"date-parts":[[2009,10,4]],"date-time":"2009-10-04T01:33:21Z","timestamp":1254620001000},"page":"1468-1475","source":"Crossref","is-referenced-by-count":34,"title":["Familial and racial determinants of tumour suppressor genes promoter hypermethylation in breast tissues from healthy women"],"prefix":"10.1111","volume":"14","author":[{"given":"R.G.","family":"Dumitrescu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Marian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Spear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.V.S.","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Convit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Seillier\u2010Moiseiwitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Freudenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.G.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23303"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-005-0481-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-199703000-00010"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205606"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gem009"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.01.029"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1799"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0028-z"},{"key":"e_1_2_6_10_2","first-page":"1596","article-title":"Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia","volume":"7","author":"Holst CR","year":"2003","journal-title":"Cancer Res."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.7.564"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0598"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr452"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095832"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2045"},{"key":"e_1_2_6_16_2","first-page":"4346","article-title":"Aberrant methylation of the estrogen receptor and E\u2010cadherin 5\u2019 CpG islands increases with malignant progression in human breast cancer","volume":"16","author":"Nass SJ","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203456"},{"key":"e_1_2_6_18_2","first-page":"335","article-title":"Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF\u20107 human breast cancer cells","volume":"8","author":"Farias EF","year":"2002","journal-title":"Cell Growth Differ."},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1078-0432.1146.11.3","article-title":"A predictor based on the somatic genomic changes of the BRCA1\/BRCA2 breast cancer tumors identifies the non\u2010BRCA1\/BRCA2 tumors with BRCA1 promoter hypermethylation","volume":"3","author":"Alvarez S","year":"2005","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11508"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.04.030"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/1078-0432.166.11.1","article-title":"Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk","volume":"1","author":"Lewis CM","year":"2005","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1657"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.2.147"},{"key":"e_1_2_6_25_2","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"8","author":"Esteller M","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690041"},{"key":"e_1_2_6_27_2","first-page":"3347","article-title":"Methylation of the BRCA1 gene in sporadic breast cancer.","volume":"16","author":"Dobrovic A","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_28_2","first-page":"5954","article-title":"Predicting lung cancer by detecting aberrant promoter methylation in sputum","volume":"21","author":"Palmisano WA","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_6_29_2","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population\u2010based study","volume":"19","author":"Baldwin RL","year":"2000","journal-title":"Cancer Res."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-5-451"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205605"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/35054579"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0407"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.8.5642"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.1206"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000155"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.2.710"},{"key":"e_1_2_6_38_2","unstructured":"American Cancer Society.Cancer Facts and Figures2008;9\u201311(Available fromhttp:\/\/www.cancer.org\/docroot\/stt\/content\/stt_1x_cancer_facts_and_figures_2008.asp)."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jncimonographs\/lgi044"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.21.2492"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0514"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21588"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006534-200009020-00001","article-title":"Breast cancer following breast reduction surgery in Sweden","volume":"4","author":"Boice JD","year":"2000","journal-title":"Plast Reconstr Surg."},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2005.09.011"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010201)91:3<478::AID-CNCR1025>3.0.CO;2-5"},{"key":"e_1_2_6_46_2","unstructured":"IARC.Cancer Incidence Mortality and Prevalence Worldwide.2004"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1582-4934.2009.00924.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1582-4934.2009.00924.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T03:31:27Z","timestamp":1698895887000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1582-4934.2009.00924.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":45,"journal-issue":{"issue":"6b","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1582-4934.2009.00924.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00924.x","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}